Extract from the Register of European Patents

EP About this file: EP2152074

EP2152074 - COMPOSITIONS OF (-)-E-10-OH-NT AND METHODS FOR THEIR SYNTHESIS AND USE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  29.11.2013
Database last updated on 11.04.2026
Most recent event   Tooltip29.11.2013Application deemed to be withdrawnpublished on 01.01.2014  [2014/01]
Applicant(s)For all designated states
Adolor Corporation
700 Pennsylvania Drive
Exton, PA 19341 / US
[2010/07]
Inventor(s)01 / LE BOURDONNEC, Bertrand
317 Ivy Lane
East Fallowfield, PA 19320 / US
02 / DOLLE, Roland
536 Elliott Drive
King Of Prussia, PA 19405 / US
 [2010/07]
Representative(s)Cockerton, Bruce Roger
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2012/24]Cockerton, Bruce Roger
Carpmaels & Ransford One Southampton Row London
WC1B 5HA / GB
Former [2010/07]Sexton, Jane Helen, et al
J.A. Kemp & Co. 14 South Square Gray's Inn
GB-London WC1R 5JJ / GB
Application number, filing date08746582.922.04.2008
[2010/07]
WO2008US61189
Priority number, dateUS20070915103P30.04.2007         Original published format: US 915103 P
US20080027814P11.02.2008         Original published format: US 27814 P
US20080028122P12.02.2008         Original published format: US 28122 P
[2010/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008134325
Date:06.11.2008
Language:EN
[2008/45]
Type: A1 Application with search report 
No.:EP2152074
Date:17.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 06.11.2008 takes the place of the publication of the European patent application.
[2010/07]
Search report(s)International search report - published on:US06.11.2008
(Supplementary) European search report - dispatched on:EP24.06.2011
ClassificationIPC:A61K31/137, C07D211/32
[2011/29]
CPC:
A61K31/137 (EP,US); A61K31/045 (KR); A01N33/02 (KR);
A61K31/015 (KR); A61K9/0019 (EP,US); A61P1/04 (EP);
A61P15/10 (EP); A61P25/00 (EP); A61P25/04 (EP);
A61P25/16 (EP); A61P25/18 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P29/00 (EP); A61P5/00 (EP); A61P9/00 (EP);
A61P9/12 (EP); C07D211/32 (EP,US); A61K9/0095 (EP,US) (-)
Former IPC [2010/07]A01N33/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/07]
TitleGerman:ZUSAMMENSETZUNGEN VON (-)-E-10-OH-NT UND VERFAHREN ZU IHRER SYNTHESE UND VERWENDUNG[2010/07]
English:COMPOSITIONS OF (-)-E-10-OH-NT AND METHODS FOR THEIR SYNTHESIS AND USE[2010/07]
French:COMPOSITIONS DE (-)-E-10-OH-NT, PROCÉDÉS DE SYNTHÈSE ET UTILISATION[2010/07]
Entry into regional phase26.11.2009National basic fee paid 
26.11.2009Search fee paid 
26.11.2009Designation fee(s) paid 
26.11.2009Examination fee paid 
Examination procedure26.11.2009Examination requested  [2010/07]
10.05.2012Amendment by applicant (claims and/or description)
06.03.2013Despatch of a communication from the examining division (Time limit: M04)
17.07.2013Application deemed to be withdrawn, date of legal effect  [2014/01]
23.08.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2014/01]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  06.03.2013
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
10.05.2012Request for further processing filed
10.05.2012Full payment received (date of receipt of payment)
Request granted
10.07.2012Decision despatched
Fees paidRenewal fee
26.04.2010Renewal fee patent year 03
25.04.2011Renewal fee patent year 04
25.04.2012Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.04.201306   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]   L. BERTILSSON ET AL.: "Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients", PHARMACOLOGY & TOXICOLOGY, vol. 68, no. 2, 1991, pages 100 - 103, XP002640018, ISSN: 0901-9928 [Y] 1-10,17 * figure 2; tables 1, 2 *

DOI:   http://dx.doi.org/10.1111/j.1600-0773.1991.tb02044.x
 [Y]   E. NUSSER ET AL.: "Enantioselective formation and disposition of (E)- and (Z)-10-hydroxynortriptyline", DRUG METABOLISM AND DISPOSITION, vol. 16, no. 3, 1988, pages 509 - 511, XP008124284, ISSN: 0090-9556 [Y] 1-10,17 * tables 2, 3 *
 [Y]   E. DUMONT ET AL.: "Glucuronidation of the enantiomers of E-10-hydroxynortripyline in human and rat liver microsomes", PHARMACOLOGY & TOXICOLOGY, vol. 61, no. 5, 1987, XP002640019, ISSN: 0901-9928 [Y] 1-10,17 * tables 1-4 *
 [Y]   U. BREYER-PFAFF, K. NILL: "High-affinity stereoselective reduction of the enantiomers of ketotifen and of ketonic nortriptyline metabolites by aldo-keto reductases from human liver", BIOCHEMICAL PHARMACOLOGY, vol. 59, no. 3, 2000, pages 249 - 260, XP002640020, ISSN: 0006-2952 [Y] 1-10,17 * table 4 *

DOI:   http://dx.doi.org/10.1016/S0006-2952(99)00319-6
 [Y]   DAHL-PUUSTINEN M L ET AL: "Glucuronidation of E-10-hydroxynortriptyline in human liver, kidney, and intestine. Organ-specific differences in enantioselectivity", DRUG METABOLISM AND DISPOSITION, WILLIAMS AND WILKINS, BALTIMORE, MD, US, vol. 17, no. 4, 1 July 1989 (1989-07-01), pages 433 - 436, XP009149045, ISSN: 0090-9556 [Y] 1-10,17 * figures 1-3; table 1 *
 [Y]   DAHL-PUUSTINEN M-L ET AL: "Stereoselective disposition of racemic E-10-hydroxynortriptyline in human beings", CLINICAL PHARMACOLOGY AND THERAPEUTICS, NATURE PUBLISHING GROUP, US, vol. 45, no. 6, 1 June 1989 (1989-06-01), pages 650 - 656, XP009149014, ISSN: 0009-9236 [Y] 1-10,17 * figures 1-3; tables I-III *

DOI:   http://dx.doi.org/10.1038/clpt.1989.86
 [Y]   BREYER-PFAFF U ET AL: "Stereoselective reversible ketone formation from 10-hydroylated nortriptyline metabolites in human liver", XENOBIOTICA, TAYLOR AND FRANCIS, LONDON, GB, vol. 25, no. 12, 1 January 1995 (1995-01-01), pages 1311 - 1326, XP009149007, ISSN: 0049-8254 [Y] 1-10,17 * tables 7, 8 *

DOI:   http://dx.doi.org/10.3109/00498259509061920
 [Y]   HEIMSTAD ET AL: "Molecular Structure and Dynamics of the Four 10-hydroxynortriptyline Isomers", NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHING, NEW YORK, NY, US, vol. 6, no. 3, 1 January 1992 (1992-01-01), pages 137 - 144, XP009149052, ISSN: 0893-133X [Y] 1-10,17 * the whole document *
 [Y]   PFANDL B ET AL: "Stereoselective inhibition of nortriptyline hydroxylation in man by quinidine", XENOBIOTICA, TAYLOR AND FRANCIS, LONDON, GB, vol. 22, no. 6, 1 January 1992 (1992-01-01), pages 721 - 730, XP009149046, ISSN: 0049-8254 [Y] 1-10,17 * figures 1-3; tables 1, 2 *

DOI:   http://dx.doi.org/10.3109/00498259209053134
 [Y]   R. M. LANE, G. B. BAKER: "Chirality and Drugs Used in Psyciatry: Nice to Know or Need to know?", CELLULAR AND MOLECULAR NEUROBIOLOGY, vol. 19, no. 3, 1999, pages 355 - 372, XP002640021 [Y] 1-10,17 * page 365 - page 366 *

DOI:   http://dx.doi.org/10.1023/A:1006997731966
 [A]   NORDIN ET AL: "Antidepressant and Anxiolytic Profiles of E-10-Hydroxynortriptyline on Electrocorticograms of Rats", NEUROPSYCHOBIOLOGY, KARGER AG, BASEL, CH, vol. 34, no. 1, 1 January 1996 (1996-01-01), pages 44 - 48, XP009149042, ISSN: 0302-282X [A] 1-10,17 * the whole document *

DOI:   http://dx.doi.org/10.1159/000119290
International search[Y]   NUSSER ET AL.: "Enantioselective formation and disposition of (E)- and (Z)-10-hydroxynortriptyline", DRUG METAB. DISPOS., 1988, XP008124284 [Y]
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.